Navigation Links
A culprit behind brain tumor resistance to therapy
Date:3/5/2012

Persistent protein expression may explain why tumors return after therapy in glioblastoma patients, according to a study published on March 5th in the Journal of Experimental Medicine.

Current therapy for glioblastoma, the most prevalent malignant brain tumor in adults, includes targeting a protein called VEGF, which promotes the growth of blood vessels to the tumor. Unfortunately, in most glioblastoma patients treated with anti-VEGF drugs, tumors return shortly after treatment.

Through an international collaboration, Jiri Bartek, Jeremy Rich, and colleagues now show that these recurring tumors express a perpetually activated form of the VEGF receptor. This active VEGF receptor drives growth of the tumor even when VEGF is blocked. Directly inhibiting the VEGF receptor, however, killed the tumors and extended the survival of tumor-bearing mice that were resistant to VEGF blockade.

These results suggest that blocking this active VEGF receptor may represent an alternative treatment option in glioblastoma cases where VEGF targeting has failed.


'/>"/>

Contact: Rita Sullivan
news@rupress.org
212-327-8603
Rockefeller University Press
Source:Eurekalert

Page: 1

Related medicine news :

1. Researchers identify breast cancer culprits
2. Lung cancer culprit could offer target for therapy, UT Southwestern researchers report
3. Key culprit identified in breast cancer metastasis
4. Researchers search for culprit behind dry eyes, mouths and more
5. New culprit found in Lou Gehrigs disease
6. Expert Panel Pinpoints Environmental Culprits in Breast Cancer
7. Extra Calories, Low Protein Are Culprits in Weight Gain
8. Researchers discover new culprit in atherosclerosis
9. New culprit discovered in T-cell acute lymphoblastic leukemia
10. Gene Might Be a Culprit in Sudden Infant Death for Boys
11. Low levels of natural antibodies behind stroke
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... GA (PRWEB) , ... February 22, 2017 , ... Super-Sod ... 25 and 26 event in Athens, Georgia. , A shift from Super-Sod’s simple Athens ... in Georgia. , For the booth, grass seed plant manager Chris Roquemore constructed furniture ...
(Date:2/22/2017)... ... ... BrightStar Care Charleston , a home care and medical staffing agency, will ... on Aging’s Senior Expo on Thursday, March 23, 2017, at the Omar Convention ... our community. We are thrilled to participate in this event because we believe it ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... ... solutions for supply chain management (SCM) and spend management, today announced that Keppel ... save time, and simplify expense tracking. , “We are excited to announce ...
(Date:2/21/2017)... ... February 21, 2017 , ... ... introduced five new hospital-grade power extension cords that meet the most current standards. ... the 2012 edition of the National Fire Protection Association (NFPA) 101 – Life ...
(Date:2/21/2017)... ... February 21, 2017 , ... Individuals who have been diagnosed ... surgery, treatment, therapy and management. Regular exercise in proper environments has been shown ... their diseases. On February 23, 2017, 1:00-2:00 p.m. E.S.T., a dynamic HydroWorx ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... 22, 2017 Oncternal Therapeutics, Inc., a ... rare and common malignancies, today announced the closing ... company intends to use the proceeds to further ... to advance preclinical development of a new ROR1-targeted ... a first-in-class anti-ROR1 monoclonal antibody being developed to ...
(Date:2/22/2017)...  CVS Pharmacy is the first national retail pharmacy ... (PHO), the primary source of artificial trans fats in ... products. The retailer now offers over 600 exclusive snack ... fats. This comes a year and a half ahead of ... for processed foods to be reformulated without artificial trans ...
(Date:2/22/2017)... 2017 Des scanners sur smartphone destinés aux professionnels ... Europe , au Moyen-Orient et en Afrique  ... Clarius Mobile Health , une société de santé ... au Canada , a annoncé aujourd,hui qu,elle a reçu ... fil Clarius C3 et L7, destinés à être utilisés par des professionnels ...
Breaking Medicine Technology: